» Articles » PMID: 31083436

Sickle Cell Anaemia Prevalence Among Newborns in the Brazilian Amazon-Savanna Transition Region

Abstract

Sickle cell anaemia is one of the most common hemoglobinopathies worldwide and an important public health problem in Brazil. This study evaluated the prevalence of sickle cell anaemia and its traits in newborns from the Amazon-Savanna Transition Region in the state of Maranhão, Brazil. A cross-sectional study was carried out, based on data from neonatal screening tests performed in 2013-2015 in Maranhão. The Hardy-Weinberg theorem was applied to analyse the frequency of expected homozygotes based on HbSS phenotype. A spatial-temporal distribution analysis was performed to delimit the regions with the greatest number of newborn cases with sickle cell anaemia. Of 283,003 newborns, 162 were found to have sickle cell anaemia, while 10,794 had a sickle cell trait, with a prevalence of 0.05% and 3.8%, respectively. The prevalence of expected homozygotes was higher in the North Region and in the state capital of Maranhão. This study may contribute to existing social and public health actions or the creation of new strategies for sickle cell disease in endemic areas in Brazil to improve the quality of life.

Citing Articles

Evaluation of Mandibular Bone Microstructure in CT Scans of People with Sickle Cell Disease.

Almeida V, Soares M, Leite-Ribeiro P, Rubira-Bullen I, Lins-Kusterer L, Sarmento V Eur J Dent. 2023; 18(1):356-359.

PMID: 37729929 PMC: 10959614. DOI: 10.1055/s-0043-1771200.


Systematic Literature Review Shows Gaps in Data on Global Prevalence and Birth Prevalence of Sickle Cell Disease and Sickle Cell Trait: Call for Action to Scale Up and Harmonize Data Collection.

Colombatti R, Hegemann I, Medici M, Birkegard C J Clin Med. 2023; 12(17).

PMID: 37685604 PMC: 10488271. DOI: 10.3390/jcm12175538.


Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.

Piel F, Rees D, DeBaun M, Nnodu O, Ranque B, Thompson A Lancet Haematol. 2023; 10(8):e633-e686.

PMID: 37451304 PMC: 11459696. DOI: 10.1016/S2352-3026(23)00096-0.


Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence.

Cancado R, Costa F, Lobo C, Migliavaca C, Falavigna M, Souza Filho H Blood Adv. 2023; 7(15):3783-3792.

PMID: 37104056 PMC: 10393747. DOI: 10.1182/bloodadvances.2022008938.


Neonatal Screening for Sickle Cell Disease in Congo.

Elira Dokekias A, Ocko Gokaba L, Simo Louokdom J, Ocini L, Galiba Atipo Tsiba F, Ondzotto Ibatta C Anemia. 2022; 2022:9970315.

PMID: 35154827 PMC: 8831066. DOI: 10.1155/2022/9970315.


References
1.
de Castro Lobo C, Bueno L, Moura P, Ogeda L, Castilho S, de Carvalho S . [Neonatal screening for hemoglobinopathies in Rio de Janeiro, Brazil]. Rev Panam Salud Publica. 2003; 13(2-3):154-9. DOI: 10.1590/s1020-49892003000200018. View

2.
Adorno E, David Couto F, de Moura Neto J, Menezes J, Rego M, Reis M . Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil. Cad Saude Publica. 2005; 21(1):292-8. DOI: 10.1590/s0102-311x2005000100032. View

3.
Aleluia M, da Guarda C, Santiago R, Fonseca T, Neves F, de Souza R . Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia. Lipids Health Dis. 2017; 16(1):74. PMC: 5387254. DOI: 10.1186/s12944-017-0454-1. View

4.
Ramalho R, Ramalho A, Oliveira C, Aguiar-Oliveira M . [Evolution of the screening program for congenital hypothyroidism and phenylketonuria in the Sergipe State from 1995 to 2003]. Arq Bras Endocrinol Metabol. 2005; 48(6):890-6. DOI: 10.1590/s0004-27302004000600017. View

5.
Eller R, Silva D . Evaluation of a neonatal screening program for sickle-cell disease. J Pediatr (Rio J). 2016; 92(4):409-13. DOI: 10.1016/j.jped.2015.10.002. View